Top Markets
#1 Akedo Akedo +192.55%
#2 ONFA ONFA +54.23%
#3 Talus Network Talus Network +23.61%
#4 Osaka Protocol Osaka Protocol +21.61%
#5 Wrapped Krown Wrapped Krown +19.87%
#6 Metaplex Metaplex +18.77%
#7 DODO DODO +18.36%
#8 eCash eCash +16.58%
#9 EVAA Protocol EVAA Protocol +16.23%
#10 Black Phoenix Black Phoenix +15.49%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Pfizer Inc. Pfizer Inc.

Pfizer Inc.

PFE
Rank in Stocks #146
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells... Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Share Price
$24.25
Market Cap
$138.21B
Change (1 day)
-0.94%
Change (1 year)
194.85%
Country
US
Trade Pfizer Inc. (PFE)

Category

Healthcare
Revenue for Pfizer Inc. (PFE)
Revenue in Jul 2026 TTM: 0
According to Pfizer Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Pfizer Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 $72.25B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $96.36B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $62.82B -
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $65.59B -
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 $56.05B -
CH